Specialized team of scientists
Viroclinics Biosciences is a leader in the strongly growing and very dynamic market of diagnostic services for clinical and pre-clinical studies organized by pharmaceutical companies and vaccine manufacturers. As a service organization we offer immunological, serological, virological and molecular analyses of any type of sample. In addition we offer logistic and data management services, including bioinformatics. We have customers from all over the world, and our analyses encompass many viruses. For more information about our company, please visit our website: www.viroclinics.com.
Professionalism and high quality standards are hallmarks of our organization. Our company is dynamic and diverse, a fascinating opportunity for professionals looking for an environment with emphasis on taking initiative, motivation to achieve, focus on results, flexibility, and the ability to learn and cooperate. Our company is steadily growing and in recent months we obtained several new requests to participate in global phase-2 and phase-3 drug development programs and we obtained a large 4-years contract to help improve vaccines with a global health impact.
We work with highly motivated top professionals and scientists in our field, national and international. Are you such an enthusiastic professional/scientist, and do you want to become a member of our team and work with us to achieve our ambitious goals? Then you are more than welcome to apply for the position of:
Director HBV Business Development
In this position you will be heading the HBV business development effort of the company and report directly to the VP business development of the company.
You will be responsible for the acquisition of HBV or other hepatitis related clinical trial services projects for antivirals and/or vaccines.
You will collaborate with the scientific staff of the company and build teams of diverse expertise to approach and convince new and existing customers to implement our services in their clinical trials. You will maintain adequate communication with current relations to ensure timely response to new study opportunities.
We are looking for a candidate who wants to be part of a dynamic, diverse and international science-based commercial organization. Viroclinics Biosciences is a rapidly growing company. Therefore, the role of Director HBV Business Development is an excellent opportunity for someone who thrives in a growing organization. With your knowledge and skills you will be further developing the HBV business of our company. With your work experience(s), education, competences and personality you are an ideal fit for the following profile: We expect you to have experience as business developer in a life science area, preferably clinical trial services. Experience as business developer in the area of hepatitis, either pharmaceutical drug development, clinical trials or laboratory services will be a huge advantage.
Career perspective & development
You will embark on this new role with a custom-designed induction program. You can expect a personal development plan, consisting of:
- Internal training by leading professionals and scientists;
- Our growth strategy allows for the option of a diverse career path;
- Participation in international conferences on Hepatitis and HBV in particular to sustain and expand a network.
Conform education, experience, and company policy. We offer a 1-year contract with the goal to extend to a permanent position. Depending on the candidate exceptions can be made.
For any question you may have, please contact Elina van Herwijnen, Vice President HRM at Herwijnen@viroclinics.com or by phone 088 6684741. Please send your CV and motivation letter by e-mail to Carla Coors, Office Manager / HRM Assistant at HR@viroclinics.com.
End date: 30-Nov-2017
Acquisition by recruitment agencies regarding this job vacancy will not be appreciated.
OUR LATEST NEWS
The French ministry of research and innovation approves Viroclinics Biosciences as an intermediate vendor for The French Tax Credit Incentive (Crédit d’Impôt Recherche or CIR), a tax relief measure for companies focused on Research & Development activities.
Parcom Capital has acquired the successful clinical research organisation Viroclinics Biosciences. Viroclinics believes Parcom is the perfect partner to help it realise its growth ambitions.
Viroclinics Biosciences serves as a virology contract research organization in the bio pharmaceutical community with preclinical, clinical diagnostic, assay development and clinical trial logistics services. Especially with extensive experience in clinical and...